Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tong Lin

Showing results (831-840 of 867) with videos related to

Pageof 87
Sort By:
Blood Cancer Journal|December 7, 2021
Dynamic assessment of measurable residual disease in favorable-risk acute myeloid leukemia in first remission, treatment, and outcomesSijian Yu, Tong Lin, Danian Nie, et al.
The New England Journal of Medicine|May 6, 2026
Daraxonrasib in Previously Treated Advanced <i>RAS</i>-Mutated Pancreatic CancerBrian M Wolpin, Wungki Park, Ignacio Garrido-Laguna, et al.
Neuro-Oncology Advances|January 28, 2021
Outcome and molecular analysis of young children with choroid plexus carcinoma treated with non-myeloablative therapy: results from the SJYC07 trialAnthony P Y Liu, Gang Wu, Brent A Orr, et al.
Biomed Research International|August 28, 2014
The effects of the context-dependent codon usage bias on the structure of the nsp1α of porcine reproductive and respiratory syndrome virusYao-zhong Ding, Ya-nan You, Dong-jie Sun, et al.
Neuro-Oncology|April 16, 2025
FOXR2 activation is not exclusive of CNS neuroblastomaAlexa N Siskar, Emily Hanzlik, Maria F Cardenas, et al.
Neuro-Oncology|October 29, 2025
An integrated analysis of three medulloblastoma clinical trials refines risk-stratification approaches for reducing toxicity and improving survivalAuthors Kyle S Smith, Sandeep K Dhanda, Catherine A Billups, et al.
Acta Neuropathologica|December 23, 2019
Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trialsAnthony P Y Liu, Brian Gudenas, Tong Lin, et al.
The Prostate|October 1, 2025
Impact of Human Development Index Category on Prostate Cancer Characteristics in AsiaShinichi Sakamoto, Xue Zhao, Mizuki Onozawa, et al.
Acta Neuropathologica|December 6, 2019
Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trialsAnthony P Y Liu, Brian Gudenas, Tong Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2015
Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032Giles W Robinson, Brent A Orr, Gang Wu, et al.
Pageof 87

Showing results (831-840 of 867) with videos related to

Sort By:
Pageof 87
Blood Cancer Journal|December 7, 2021
Dynamic assessment of measurable residual disease in favorable-risk acute myeloid leukemia in first remission, treatment, and outcomesSijian Yu, Tong Lin, Danian Nie, et al.
The New England Journal of Medicine|May 6, 2026
Daraxonrasib in Previously Treated Advanced <i>RAS</i>-Mutated Pancreatic CancerBrian M Wolpin, Wungki Park, Ignacio Garrido-Laguna, et al.
Neuro-Oncology Advances|January 28, 2021
Outcome and molecular analysis of young children with choroid plexus carcinoma treated with non-myeloablative therapy: results from the SJYC07 trialAnthony P Y Liu, Gang Wu, Brent A Orr, et al.
Biomed Research International|August 28, 2014
The effects of the context-dependent codon usage bias on the structure of the nsp1α of porcine reproductive and respiratory syndrome virusYao-zhong Ding, Ya-nan You, Dong-jie Sun, et al.
Neuro-Oncology|April 16, 2025
FOXR2 activation is not exclusive of CNS neuroblastomaAlexa N Siskar, Emily Hanzlik, Maria F Cardenas, et al.
Neuro-Oncology|October 29, 2025
An integrated analysis of three medulloblastoma clinical trials refines risk-stratification approaches for reducing toxicity and improving survivalAuthors Kyle S Smith, Sandeep K Dhanda, Catherine A Billups, et al.
Acta Neuropathologica|December 23, 2019
Correction to: Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trialsAnthony P Y Liu, Brian Gudenas, Tong Lin, et al.
The Prostate|October 1, 2025
Impact of Human Development Index Category on Prostate Cancer Characteristics in AsiaShinichi Sakamoto, Xue Zhao, Mizuki Onozawa, et al.
Acta Neuropathologica|December 6, 2019
Risk-adapted therapy and biological heterogeneity in pineoblastoma: integrated clinico-pathological analysis from the prospective, multi-center SJMB03 and SJYC07 trialsAnthony P Y Liu, Brian Gudenas, Tong Lin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2015
Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032Giles W Robinson, Brent A Orr, Gang Wu, et al.
Pageof 87